MA52362A - Procédé de préparation de d'acide 2-(1-(tert-butoxylcarbonyl)-pipéridine-4-yl) benzoïque - Google Patents
Procédé de préparation de d'acide 2-(1-(tert-butoxylcarbonyl)-pipéridine-4-yl) benzoïqueInfo
- Publication number
- MA52362A MA52362A MA052362A MA52362A MA52362A MA 52362 A MA52362 A MA 52362A MA 052362 A MA052362 A MA 052362A MA 52362 A MA52362 A MA 52362A MA 52362 A MA52362 A MA 52362A
- Authority
- MA
- Morocco
- Prior art keywords
- butoxylcarbonyl
- piperidine
- tert
- preparation
- benzoic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/02—Preparation by ring-closure or hydrogenation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862679586P | 2018-06-01 | 2018-06-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52362A true MA52362A (fr) | 2021-03-03 |
Family
ID=66912982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052362A MA52362A (fr) | 2018-06-01 | 2019-05-29 | Procédé de préparation de d'acide 2-(1-(tert-butoxylcarbonyl)-pipéridine-4-yl) benzoïque |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10640467B2 (fr) |
| EP (1) | EP3784655B1 (fr) |
| JP (1) | JP7252978B2 (fr) |
| CN (1) | CN112204007B (fr) |
| ES (1) | ES2960492T3 (fr) |
| MA (1) | MA52362A (fr) |
| WO (1) | WO2019232010A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230372318A1 (en) | 2022-03-28 | 2023-11-23 | Theravance Biopharma R&D Ip, Llc | Methods for treating a subject having multiple system atrophy |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2891066A (en) | 1957-08-14 | 1959-06-16 | Parke Davis & Co | 4,o-substituted phenyl 1 alkanol piperidines and esters thereof |
| HUT74733A (en) * | 1993-11-09 | 1997-02-28 | Merck & Co Inc | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
| AU2009313951B2 (en) | 2008-11-14 | 2015-03-12 | Theravance Biopharma R&D Ip, Llc | 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds |
| IL288194B2 (en) | 2016-08-30 | 2024-03-01 | Theravance Biopharma R& D Ip Llc | [- 2 (- 6,4,2--trifluorophenoxymethyl) phenyl[piperidine for use in the treatment of neurogenic hypotension on standing |
-
2019
- 2019-05-29 JP JP2020566695A patent/JP7252978B2/ja active Active
- 2019-05-29 US US16/425,166 patent/US10640467B2/en active Active
- 2019-05-29 ES ES19731448T patent/ES2960492T3/es active Active
- 2019-05-29 MA MA052362A patent/MA52362A/fr unknown
- 2019-05-29 EP EP19731448.7A patent/EP3784655B1/fr active Active
- 2019-05-29 WO PCT/US2019/034332 patent/WO2019232010A1/fr unknown
- 2019-05-29 CN CN201980034885.8A patent/CN112204007B/zh active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3784655B1 (fr) | 2023-10-04 |
| JP2021526142A (ja) | 2021-09-30 |
| US20190367455A1 (en) | 2019-12-05 |
| US10640467B2 (en) | 2020-05-05 |
| EP3784655C0 (fr) | 2023-10-04 |
| EP3784655A1 (fr) | 2021-03-03 |
| JP7252978B2 (ja) | 2023-04-05 |
| CN112204007B (zh) | 2023-06-20 |
| WO2019232010A1 (fr) | 2019-12-05 |
| ES2960492T3 (es) | 2024-03-05 |
| CN112204007A (zh) | 2021-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA53172A (fr) | Composés de sulfonimidamide en tant qu'inhibiteurs de l'activité de l'interleukine 1 | |
| MA49045A (fr) | Compositions et procédés destinés à la distribution régulée d'acide | |
| BR112013016982A2 (pt) | formas polimórficas de ácido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acético e usos destes | |
| BR112015000160A2 (pt) | fabricação de ácido 2-(5-bromo-4-(4-ciclopropil hidronaftalen-1-il)-4h-1,2,4-triazol-3-il-tio) acético | |
| MA55917A (fr) | Procédé de cristallisation de dérivés d'aripiprazole dans des formulations à libération prolongée pour le traitement de la schizophrénie | |
| FR3049601B1 (fr) | Procede ameliore de production d'acide (meth)acrylique | |
| BR112018073951A2 (pt) | forma cristalina inovadora de n-[5-(3,5-difluoro-benzil)-1h-indazol-3-il]-4-(4-metil-piperazin-1-il)-2-(tetra-hidro-piran-4-ilamino)-benzamida | |
| EA201791226A1 (ru) | Композиции, содержащие 2-((1-(2-(4-фторфенил)-2-оксоэтил)пиперидин-4-ил)метил)изоиндолин-1-он для лечения шизофрении | |
| MA53643A (fr) | Dioxocyclobuténylamino-3-hydroxy-picolinamides n-substitués utiles en tant qu'inhibiteurs de ccr6 | |
| MA52877A (fr) | Acide hyaluronique stabilisé | |
| MA52362A (fr) | Procédé de préparation de d'acide 2-(1-(tert-butoxylcarbonyl)-pipéridine-4-yl) benzoïque | |
| MA52750A (fr) | Nouveau procédé de stabilisation de nanostructures d'acide nucléique | |
| MA54522A (fr) | Composition pharmaceutique pour le traitement de l'hypertension artérielle pulmonaire | |
| MA56055A (fr) | Procédés de préparation d'acide 5-bromo-2-(3chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylique | |
| BR112015009567A2 (pt) | compostos de benzil sulfonamida novos úteis como inibidores de mogat-2 | |
| WO2017094031A3 (fr) | Nouveau procédé de préparation d'aprémilast | |
| MA50575A (fr) | Préparation d'acide phosphorique | |
| FR3034765B1 (fr) | Nouvelle methode de synthese simultanee de l'acide azelaique et de l'acide pelargonique par l'ozone | |
| MA51870A (fr) | Procédé pour la préparation de composés coupleurs de médicaments | |
| MA50630A (fr) | Procédé de préparation de dérivés d'alpha-carboxamide de pyrrolidine | |
| MA52634A (fr) | Acide nucléique pour traitement de d'allergie aux acariens | |
| DK3823952T3 (da) | Oprensning af levulinsyre | |
| MA53787A (fr) | Compositions pour réduire l'acide urique sérique | |
| MA49761A (fr) | Dérivés d'acide glycyrrhétinique de traitement de l'hyperkaliémie | |
| MA46568A (fr) | Dosage biologique de formulations d'insuline |